Literature DB >> 36001207

Metagenomic next-generation sequencing restores the diagnosis of a rare infectious complication of B cell depletion.

Margaux Garzaro1,2, Lin-Pierre Zhao3, Nathalie De Castro4, Séverine Mercier-Delarue5, Francois Camelena5,6, Sabine Pereyre7, Marie Gardette7, Béatrice Berçot5,6, Marion Malphettes3, Cécile Bébéar7, Jean-David Bouaziz8,9, Jérôme Le Goff5,10, Lionel Galicier3, Maud Salmona11,12,13.   

Abstract

A 45-year-old female patient receiving rituximab for B cell non-Hodgkin follicular lymphoma presented unexplained recurrent fever, abdominal discomfort, and pollakiuria. We performed shotgun metagenomic sequencing from peri-kidney collection that identified a co-infection with Mycoplasma hominis and Ureaplasma urealyticum. The patient recovered with sequelae after appropriate antibiotic treatment was given.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  B cell aplasia; Metagenomic next-generation sequencing; Mycoplasma hominis

Mesh：

Substances：

Year:  2022        PMID： 36001207     DOI： 10.1007/s10096-022-04484-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   5.103


  35 in total

1.  Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab.

Authors:  Stuart L Goldberg; Andrew L Pecora; Robert S Alter; Mark S Kroll; Scott D Rowley; Stanley E Waintraub; Kavita Imrit; Robert A Preti
Journal:  Blood       Date:  2002-02-15       Impact factor: 22.113

2.  Septic polyarthritis with Ureaplasma urealyticum in a patient with prolonged agammaglobulinemia and B-cell aplasia after allogeneic HSCT and rituximab pretreatment.

Authors:  C Arber; A Buser; D Heim; M Weisser; A Tyndall; A Tichelli; J Passweg; A Gratwohl
Journal:  Bone Marrow Transplant       Date:  2007-07-09       Impact factor: 5.483

Review 3.  Postoperative Mycoplasma hominis infections after neurosurgical intervention.

Authors:  Wesley J Whitson; Perry A Ball; S Scott Lollis; Jason D Balkman; David F Bauer
Journal:  J Neurosurg Pediatr       Date:  2014-05-23       Impact factor: 2.375

4.  Mycoplasmal arthritis in patients with primary immunoglobulin deficiency: clinical features and outcome in 18 patients.

Authors:  A Franz; A D Webster; P M Furr; D Taylor-Robinson
Journal:  Br J Rheumatol       Date:  1997-06

5.  The Role of B Cells in Carriage and Clearance of Mycoplasma pneumoniae From the Respiratory Tract of Mice.

Authors:  Patrick M Meyer Sauteur; Ruben C A de Groot; Silvia C Estevão; Theo Hoogenboezem; Adrianus C J M de Bruijn; Marcel Sluijter; Marjolein J W de Bruijn; Ismé M De Kleer; Rien van Haperen; Judith M A van den Brand; Debby Bogaert; Pieter L A Fraaij; Cornelis Vink; Rudi W Hendriks; Janneke N Samsom; Wendy W J Unger; Annemarie M C van Rossum
Journal:  J Infect Dis       Date:  2018-01-04       Impact factor: 5.226

Review 6.  Extragenital Mycoplasma hominis infections in adults: emphasis on immunosuppression.

Authors:  R D Meyer; W Clough
Journal:  Clin Infect Dis       Date:  1993-08       Impact factor: 9.079

7.  Mycoplasmas and ureaplasmas in patients with hypogammaglobulinaemia and their role in arthritis: microbiological observations over twenty years.

Authors:  P M Furr; D Taylor-Robinson; A D Webster
Journal:  Ann Rheum Dis       Date:  1994-03       Impact factor: 19.103

8.  Chronic cystitis and urethritis associated with ureaplasmal and mycoplasmal infection in primary hypogammaglobulinaemia.

Authors:  A D Webster; D Taylor-Robinson; P M Furr; G L Asherson
Journal:  Br J Urol       Date:  1982-06

9.  A case of Ureaplasma urealyticum septic arthritis in a patient with hypogammaglobulinemia.

Authors:  P Forgacs; R B Kundsin; S W Margles; M L Silverman; R E Perkins
Journal:  Clin Infect Dis       Date:  1993-02       Impact factor: 9.079

10.  A disseminated Mycoplasma hominis infection in a patient with an underlying defect in humoral immunity.

Authors:  Eric Nulens; Jens Van Praet; Dominik Selleslag; Thomas Van Landschoot; Dieter Dekeyzer; Patrick Descheemaecker; Marijke Reynders
Journal:  Infection       Date:  2015-11-06       Impact factor: 3.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.